Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2011 (2011), Article ID 654931, 14 pages
http://dx.doi.org/10.1155/2011/654931
Review Article

Epigenetic Effects and Molecular Mechanisms of Tumorigenesis Induced by Cigarette Smoke: An Overview

1Department of Environmental and Occupational Health, National Cheng Kung University Medical College, 138 Sheng-Li Road, Tainan 70428, Taiwan
2Institute of Molecular Medicine, National Cheng Kung University, Tainan 70428, Taiwan
3Department of Medical Sciences, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
4Division of Environmental Health and Occupational Medicine, National Health Research Institutes, No. 35 Keyan Road, Zhunan Town, Miaoli County 350, Taiwan
5Sustainable Environment Research Centre, National Cheng Kung University, Tainan 70955, Taiwan

Received 15 December 2010; Accepted 24 January 2011

Academic Editor: David Z. Qian

Copyright © 2011 Rong-Jane Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Anand, A. B. Kunnumakkara, C. Sundaram et al., “Cancer is a preventable disease that requires major lifestyle changes,” Pharmaceutical research, vol. 25, no. 9, pp. 2097–2116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. IARC, Tobacco Smoking and Tobacco Smoke, IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans, vol. 83, Inetrnational Agency for Research on Cancer, Lyon, France, Lyon, France, 2004.
  3. IARC, Some Non-Heterocyclic Polycyclic Aromatic Hydrocarbones and Some Related Exposures, vol. 92, Inetrnational Agency for Research on Cancer, Lyon, France, 2010.
  4. H. Kuper, P. Boffetta, and H. O. Adami, “Tobacco use and cancer causation: association by tumour type,” Journal of Internal Medicine, vol. 252, no. 3, pp. 206–224, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. S. S. Hecht, “Cigarette smoking: cancer risks, carcinogens, and mechanisms,” Langenbeck's Archives of Surgery, vol. 391, no. 6, pp. 603–613, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Carbone and H. I. Pass, “Multistep and multifactorial carcinogenesis: when does a contributing factor become a carcinogen?” Seminars in Cancer Biology, vol. 14, no. 6, pp. 399–405, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. P. A. Oliveira, A. Colaço, R. Chaves, H. Guedes-Pinto, L. F. P. De-La-Cruz, and C. Lopes, “Chemical carcinogenesis,” Anais da Academia Brasileira de Ciencias, vol. 79, no. 4, pp. 593–916, 2007. View at Google Scholar · View at Scopus
  8. N. Sutandyo, “Nutritional carcinogenesis,” Acta medica Indonesiana, vol. 42, no. 1, pp. 36–42, 2010. View at Google Scholar
  9. T. Sugimura, “Nutrition and dietary carcinogens,” Carcinogenesis, vol. 21, no. 3, pp. 387–395, 2000. View at Google Scholar · View at Scopus
  10. L. A. Peterson, “Formation, repair, and genotoxic properties of bulky DNA adducts formed from tobacco-specific nitrosamines,” Journal of Nucleic Acids, vol. 2010, Article ID 284935, 11 pages, 2010. View at Google Scholar
  11. G. Akopyan and B. Bonavida, “Understanding tobacco smoke carcinogen NNK and lung tumorigenesis,” International journal of oncology, vol. 29, no. 4, pp. 745–752, 2006. View at Google Scholar · View at Scopus
  12. K. P. L. Bhat and J. M. Pezzuto, “Cancer chemopreventive activity of resveratrol,” Annals of the New York Academy of Sciences, vol. 957, pp. 210–229, 2002. View at Google Scholar · View at Scopus
  13. L. Johnson, K. Mercer, D. Greenbaum et al., “Somatic activation of the K-ras oncogene causes early onset lung cancer in mice,” Nature, vol. 410, no. 6832, pp. 1111–1116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. R. A. Lubet, Z. Zhang, R. W. Wiseman, and M. You, “Use of p53 transgenic mice in the development of cancer models for multiple purposes,” Experimental Lung Research, vol. 26, no. 8, pp. 581–593, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. G. M. Williams, “Mechanisms of chemical carcinogenesis and application to human cancer risk assessment,” Toxicology, vol. 166, no. 1-2, pp. 3–10, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. S. S. Hecht, “Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines,” Chemical Research in Toxicology, vol. 11, no. 6, pp. 559–603, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. S. S. Hecht, “Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer,” Carcinogenesis, vol. 23, no. 6, pp. 907–922, 2002. View at Google Scholar · View at Scopus
  18. S. S. Hecht, “Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer,” Carcinogenesis, vol. 23, no. 6, pp. 907–922, 2002. View at Google Scholar
  19. R. K. Ross, P. A. Jones, and M. C. Yu, “Bladder cancer epidemiology and pathogenesis,” Seminars in Oncology, vol. 23, no. 5, pp. 536–545, 1996. View at Google Scholar · View at Scopus
  20. S. Raimondi, P. Maisonneuve, and A. B. Lowenfels, “Epidemiology of pancreatic cancer: an overview,” Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 12, pp. 699–708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Prokopczyk, G. Leder, N. Trushin et al., “4-Hydroxy-1-(3-pyridyl)-1-butanone, an indicator for 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone-induced DNA damage, is not detected in human pancreatic tissue,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 2, pp. 540–541, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Rivenson, D. Hoffmann, B. Prokopczyk, S. Amin, and S. S. Hecht, “Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines,” Cancer Research, vol. 48, no. 23, pp. 6912–6917, 1988. View at Google Scholar · View at Scopus
  23. Z. Jin, F. Gao, T. Flagg, and X. Deng, “Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation,” Journal of Biological Chemistry, vol. 279, no. 38, pp. 40209–40219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Cohen, D. T. Purtilo, and L. B. Ellwein, “Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis,” Modern Pathology, vol. 4, no. 3, pp. 371–382, 1991. View at Google Scholar · View at Scopus
  25. P. Dasgupta and S. P. Chellappan, “Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story,” Cell Cycle, vol. 5, no. 20, pp. 2324–2328, 2006. View at Google Scholar · View at Scopus
  26. G. Boysen and S. S. Hecht, “Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods,” Mutation Research, vol. 543, no. 1, pp. 17–30, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. D. M. DeMarini, “Genotoxicity of tobacco smoke and tobacco smoke condensate: a review,” Mutation Research, vol. 567, no. 2-3, pp. 447–474, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. G. P. Pfeifer, M. F. Denissenko, M. Olivier, N. Tretyakova, S. S. Hecht, and P. Hainaut, “Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers,” Oncogene, vol. 21, no. 48, pp. 7435–7451, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Google Scholar · View at Scopus
  30. C. Heeschen, J. J. Jang, M. Weis et al., “Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis,” Nature Medicine, vol. 7, no. 7, pp. 833–839, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. H. M. Schuller, H. K. Plummer, and B. A. Jull, “Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells,” Anatomical Record, vol. 270, no. 1, pp. 51–58, 2003. View at Google Scholar · View at Scopus
  32. H. P. S. Wong, LE. Yu, E. K. Y. Lam, E. K. K. Tai, W. K. K. Wu, and C. H. Cho, “Nicotine promotes colon tumor growth and angiogenesis through β-adrenergic activation,” Toxicological Sciences, vol. 97, no. 2, pp. 279–287, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Laag, M. Majidi, M. Cekanova, T. Masi, T. Takahashi, and H. M. Schuller, “NNK activates ERK1/2 and CREB/ATF-1 via β-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells,” International Journal of Cancer, vol. 119, no. 7, pp. 1547–1552, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. D. C. L. Lam, L. Girard, R. Ramirez et al., “Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers,” Cancer Research, vol. 67, no. 10, pp. 4638–4647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J.-M. Tournier and P. Birembaut, “Nicotinic acetylcholine receptors and predisposition to lung cancer,” Current Opinion in Oncology, vol. 23, no. 1, pp. 83–87, 2011. View at Publisher · View at Google Scholar
  36. R. D. Egleton, K. C. Brown, and P. Dasgupta, “Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis,” Trends in Pharmacological Sciences, vol. 29, no. 3, pp. 151–158, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. C.-H. Lee, C.-S. Huang, C.-S. Chen et al., “Overexpression and activation of the α9-nicotinic receptor during tumorigenesis in human breast epithelial cells,” Journal of the National Cancer Institute, vol. 102, no. 17, pp. 1322–1335, 2010. View at Publisher · View at Google Scholar
  38. C.-S. Chen, C.-H. Lee, C.-D. Hsieh et al., “Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins,” Breast Cancer Research and Treatment, vol. 125, no. 1, pp. 73–87, 2011. View at Publisher · View at Google Scholar
  39. C.-H. Lee, Y.-C. Chang, C.-S. Chen et al., “Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces α9-nicotinic acetylcholine receptor expression in human breast cancer cells,” Breast Cancer Research and Treatment. In press. View at Publisher · View at Google Scholar
  40. A. I. Chernyavsky, J. Arredondo, D. E. Vetter, and S. A. Grando, “Central role of α9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization,” Experimental Cell Research, vol. 313, no. 16, pp. 3542–3555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Trombino, A. Cesario, S. Margaritora et al., “α7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway,” Cancer Research, vol. 64, no. 1, pp. 135–145, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Wada, M. Naito, H. Kenmochi, H. Tsuneki, and T. Sasaoka, “Chronic nicotine exposure enhances insulin-induced mitogenic signaling via up-regulation of α7 nicotinic receptors in isolated rat aortic smooth muscle cells,” Endocrinology, vol. 148, no. 2, pp. 790–799, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. R. J. Chen, Y. S. Ho, H. R. Guo, and Y. J. Wang, “Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells,” Toxicological Sciences, vol. 104, no. 2, pp. 283–293, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. P.-L. Wei, Y.-J. Chang, Y.-S. Ho et al., “Tobacco-specific carcinogen enhances colon cancer cell migration through α7-nicotinic acetylcholine receptor,” Annals of Surgery, vol. 249, no. 6, pp. 978–985, 2009. View at Publisher · View at Google Scholar
  45. H. M. Schuller and M. Orloff, “Tobacco-specific carcinogenic nitrosamines: ligands for nicotinic acetylcholine receptors in human lung cancer cells,” Biochemical Pharmacology, vol. 55, no. 9, pp. 1377–1384, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Arredondo, A. I. Chernyavsky, and S. A. Grando, “Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells,” Cancer Biology and Therapy, vol. 5, no. 5, pp. 511–517, 2006. View at Google Scholar · View at Scopus
  47. B. Jull, H. Plummer, and H. Schuller, “Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells,” Journal of Cancer Research and Clinical Oncology, vol. 127, no. 12, pp. 707–717, 2001. View at Google Scholar · View at Scopus
  48. K. A. West, J. Brognard, A. S. Clark et al., “Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells,” Journal of Clinical Investigation, vol. 111, no. 1, pp. 81–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Tsurutani, S. S. Castillo, J. Brognard et al., “Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells,” Carcinogenesis, vol. 26, no. 7, pp. 1182–1195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Grozio, L. Paleari, A. Catassi et al., “Natural agents targeting the α7-nicotinic-receptor in NSCLC: a promising prospective in anti-cancer drug development,” International Journal of Cancer, vol. 122, no. 8, pp. 1911–1915, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. W. K. K. Wu, H. P. S. Wong, S. W. Luo et al., “4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via β-adrenoceptors,” Cancer Research, vol. 65, no. 12, pp. 5272–5277, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. H. M. Schuller, B. Porter, and A. Riechert, “Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters,” Journal of Cancer Research and Clinical Oncology, vol. 126, no. 11, pp. 624–630, 2000. View at Google Scholar · View at Scopus
  53. H. M. Schuller and M. Cekanova, “NNK-induced hamster lung adenocarcinomas over-express β- adrenergic and EGFR signaling pathways,” Lung Cancer, vol. 49, no. 1, pp. 35–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Y. Shin, W. K. K. Wu, K. M. Chu et al., “Functional role of β-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells,” Toxicological Sciences, vol. 96, no. 1, pp. 21–29, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. C. H. Cho and H. P. Wong, “Adrenaline and nicotine interaction in the pathogenesis of colon cancer,” Acta Oncologica, vol. 46, pp. 407–408, 2007. View at Google Scholar
  56. V. Y. Shin, W. K. K. Wu, YI. N. Ye et al., “Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2,” Carcinogenesis, vol. 25, no. 12, pp. 2487–2495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. R. J. Chen, Y. S. Ho, H. R. Guo, and Y. J. Wang, “Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells,” Toxicological Sciences, vol. 115, no. 1, pp. 118–130, 2010. View at Google Scholar
  58. H. A. N. Al-Wadei, H. K. Plummer, and H. M. Schuller, “Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter γ-aminobutyric acid,” Carcinogenesis, vol. 30, no. 3, pp. 506–511, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Gladkevich, J. Korf, V. P. Hakobyan, and K. V. Melkonyan, “The peripheral GABAergic system as a target in endocrine disorders,” Autonomic Neuroscience, vol. 124, no. 1-2, pp. 1–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. H. M. Schuller, H. A. N. Al-Wadei, and M. Majidi, “Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma,” Carcinogenesis, vol. 29, no. 10, pp. 1979–1985, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. H. M. Schuller, H. A. N. Al-Wadei, and M. Majidi, “GABA receptor is a novel drug target for pancreatic cancer,” Cancer, vol. 112, no. 4, pp. 767–778, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. H. M. Schuller, “Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?” Nature Reviews Cancer, vol. 9, no. 3, pp. 195–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. M. D.F. Askari, M.-S. Tsao, and H. M. Schuller, “The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone stimulates proliferation of immortalized human pancreatic duct epithelia through β-adrenergic transactivation of EGF receptors,” Journal of Cancer Research and Clinical Oncology, vol. 131, no. 10, pp. 639–648, 2005. View at Publisher · View at Google Scholar
  64. M. D. Siwicky, J. J. Petrik, and R. A. Moorehead, “The function of IGF-IR in NNK-mediated lung tumorigenesis,” Lung Cancer, vol. 71, no. 1, pp. 11–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. R.-Y. Huang, M.-Y. Li, M. K.Y. Hsin et al., “4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A 2 and its receptor,” Oncogene, vol. 30, no. 1, pp. 106–116, 2011. View at Publisher · View at Google Scholar
  66. N. Nadiminty, W. Lou, S. O. Lee, X. Lin, D. L. Trump, and A. C. Gao, “Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 19, pp. 7264–7269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Bláha, P. Kapplová, J. Vondráček, B. Upham, and M. Machala, “Inhibition of gap-junctional intercellular communication by environmentally occuring polycyclic aromatic hydrocarbons,” Toxicological Sciences, vol. 65, no. 1, pp. 43–51, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. S. L. Tannheimer, S. P. Ethier, K. K. Caldwell, and S. W. Burchiel, “Benzo[α]pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line,” Carcinogenesis, vol. 19, no. 7, pp. 1291–1297, 1998. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Plíšková, J. Vondráček, B. Vojtěšek, A. Kozubík, and M. Machala, “Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events,” Toxicological Sciences, vol. 83, no. 2, pp. 246–256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Vondráček, A. Kozubik, and M. Machala, “Modulation of estrogen receptor-dependent reporter construct activation and G/G-S-phase transition by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells,” Toxicological Sciences, vol. 70, no. 2, pp. 193–201, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. K. F. Arcaro, P. W. O'Keefe, YI. Yang, W. Clayton, and J. F. Gierthy, “Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells,” Toxicology, vol. 133, no. 2-3, pp. 115–127, 1999. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Chen, N. Nguyen, K. Tamura, M. Karin, and R. H. Tukey, “The role of the Ah receptor and p38 in benzo[a]pyrene-7,8-dihydrodiol and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced apoptosis,” Journal of Biological Chemistry, vol. 278, no. 21, pp. 19526–19533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Fu, C. Wang, Z. Li, T. Sakamaki, and R. G. Pestell, “Minireview: "Cyclin D1: normal and abnormal functions,” Endocrinology, vol. 145, no. 12, pp. 5439–5447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Dasgupta, S. Rastogi, S. Pillai et al., “Nicotine induces cell proliferation by β-arrestin-mediated activation of Src and Rb-Raf-1 pathways,” Journal of Clinical Investigation, vol. 116, no. 8, pp. 2208–2217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. S. Ho, C. H. Chen, Y. J. Wang et al., “Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFκB activation and cyclin D1 up-regulation,” Toxicology and Applied Pharmacology, vol. 205, no. 2, pp. 133–148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Chu, J. Guo, and C. Y. Chen, “Long-term exposure to nicotine, via Ras pathway, induces cyclin D1 to stimulate G cell cycle transition,” Journal of Biological Chemistry, vol. 280, no. 8, pp. 6369–6379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. I. Vivanco and C. L. Sawyers, “The phosphatidylinositol 3-kinase-AKT pathway in human cancer,” Nature Reviews Cancer, vol. 2, no. 7, pp. 489–501, 2002. View at Google Scholar · View at Scopus
  78. X. Chen, F. Bai, O. Sokol et al., “A critical role for DAP10 and DAP12 in CD8 T cell-mediated tissue damage in large granular lymphocyte leukemia,” Blood, vol. 113, no. 14, pp. 3226–3234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Xu, H. Huang, C. Pan, B. Zhang, X. Liu, and L. Zhang, “Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells,” International Journal of Oral and Maxillofacial Surgery, vol. 36, no. 8, pp. 739–744, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. H. Mai, W. S. May, F. Gao, Z. Jin, and X. Deng, “A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis,” Journal of Biological Chemistry, vol. 278, no. 3, pp. 1886–1891, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Bose, H. Zhang, K. B. Udupa, and P. Chowdhury, “Activation of p-ERK1/2 by nicotine in pancreatic tumor cell line AR42J: effects on proliferation and secretion,” American Journal of Physiology, vol. 289, no. 5, pp. G926–G934, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. P. Chowdhury, C. Bose, and K. B. Udupa, “Nicotine-induced proliferation of isolated rat pancreatic acinar cells: effect on cell signalling and function,” Cell Proliferation, vol. 40, no. 1, pp. 125–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Dasgupta, R. Kinkade, B. Joshi, C. DeCook, E. Haura, and S. Chellappan, “Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 16, pp. 6332–6337, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Zhao, M. Xin, T. Wang, Y. Zhang, and X. Deng, “Nicotine enhances the antiapoptotic function of mcl-1 through phosphorylation,” Molecular Cancer Research, vol. 7, no. 12, pp. 1954–1961, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Y. Li, J. Yip, M. K. Y. Hsin et al., “Haem oxygenase-1 plays a central role in NNK-mediated lung carcinogenesis,” European Respiratory Journal, vol. 32, no. 4, pp. 911–923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. R. K. Semple, V. K. K. Chatterjee, and S. O'Rahilly, “PPARγ and human metabolic disease,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 581–589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. C. S. Aung, H. M. Faddy, E. J. Lister, G. R. Monteith, and S. J. Roberts-Thomson, “Isoform specific changes in PPARα and β in colon and breast cancer with differentiation,” Biochemical and Biophysical Research Communications, vol. 340, no. 2, pp. 656–660, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. L. Xu, C. Han, K. Lim, and T. Wu, “Cross-talk between peroxisome proliferator-activated receptor δ and cytosolic phospholipase A2α/cyclooxygenase-2/prostaglandin E2 signaling pathways in human hepatocellular carcinoma cells,” Cancer Research, vol. 66, no. 24, pp. 11859–11868, 2006. View at Publisher · View at Google Scholar
  89. E. E. Girroir, H. E. Hollingshead, A. N. Billin et al., “Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines,” Toxicology, vol. 243, no. 1-2, pp. 236–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. X. Sun, J. D. Ritzenthaler, X. Zhong, Y. Zheng, J. Roman, and S. Han, “Nicotine stimulates PPARβ/δ expression in human lung carcinoma cells through activation of P13K/mTOR and suppression of AP-2α,” Cancer Research, vol. 69, no. 16, pp. 6445–6453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. V. G. Keshamouni, R. C. Reddy, D. A. Arenberg et al., “Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer,” Oncogene, vol. 23, no. 1, pp. 100–108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Y. Li, T. W. Lee, A. P. C. Yim, and G. G. Chen, “Function of PPARγ and its ligands in lung cancer,” Critical Reviews in Clinical Laboratory Sciences, vol. 43, no. 2, pp. 183–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Yuan, M. Y. Li, L. T. Ma et al., “15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer,” Thorax, vol. 65, no. 4, pp. 321–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Solhaug, M. Refsnes, M. Låg, P. E. Schwarze, T. Husøy, and J. A. Holme, “Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells,” Carcinogenesis, vol. 25, no. 5, pp. 809–819, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. D. W. Nebert, A. L. Roe, M. Z. Dieter, W. A. Solis, YI. Yang, and T. P. Dalton, “Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis,” Biochemical Pharmacology, vol. 59, no. 1, pp. 65–85, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Solhaug, M. Refsnes, and J. A. Holme, “Role of cell signalling involved in induction of apoptosis by benzo[a]pyrene and cyclopenta[c,d]pyrene in hepa1c1c7 cells,” Journal of Cellular Biochemistry, vol. 93, no. 6, pp. 1143–1154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Teranishi, T. Toyooka, T. Ohura, S. Masuda, and Y. Ibuki, “Benzo[a]pyrene exposed to solar-simulated light inhibits apoptosis and augments carcinogenicity,” Chemico-Biological Interactions, vol. 185, no. 1, pp. 4–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Wang, G. J. Hannon, and D. H. Beach, “Risky immortalization by telomerase,” Nature, vol. 405, no. 6788, pp. 755–756, 2000. View at Publisher · View at Google Scholar · View at Scopus
  99. H. W. Yim, R. J. C. Slebos, S. H. Randell et al., “Smoking is associated with increased telomerase activity in short-term cultures of human bronchial epithelial cells,” Cancer Letters, vol. 246, no. 1-2, pp. 24–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. T. Targowski, K. Jahnz-Rózyk, T. Szkoda, S. From, R. Rozyńska, and T. Płusa, “Influence of nicotine addiction on telomerase activity in malignant non-small cell lung tumorsWpływ nikotynizmu na aktywność telomerazy w niedrobnokomórkowych guzach złośliwych płuc,” Przeglad lekarski, vol. 62, no. 10, pp. 1043–1046, 2005. View at Google Scholar · View at Scopus
  101. T. Schmelzle and M. N. Hall, “TOR, a central controller of cell growth,” Cell, vol. 103, no. 2, pp. 253–262, 2000. View at Google Scholar · View at Scopus
  102. Q. Jin, D. G. Menter, LI. Mao, W. K. Hong, and HO. Y. Lee, “Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure,” Carcinogenesis, vol. 29, no. 8, pp. 1614–1622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. P. R. Smith, J. M. Cooper, G. G. Govan, A. H. V. Harding, and A. H. V. Schapira, “Smoking and mitochondrial function: a model for environmental toxins,” Quarterly Journal of Medicine, vol. 86, no. 10, pp. 657–660, 1993. View at Google Scholar · View at Scopus
  104. M. Van Der Toorn, D. J. Slebos, H. G. De Bruin et al., “Cigarette smoke-induced blockade of the mitochondrial respiratory chain switches lung epithelial cell apoptosis into necrosis,” American Journal of Physiology, vol. 292, no. 5, pp. L1211–L1218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. J. E. Bruin, M. A. Petre, S. Raha, K. M. Morrison, H. C. Gerstein, and A. C. Holloway, “Fetal and neonatal nicotine exposure in wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunction,” PLoS ONE, vol. 3, no. 10, Article ID e3371, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. J. S. Penta, F. M. Johnson, J. T. Wachsman, and W. C. Copeland, “Mitochondrial DNA in human malignancy,” Mutation Research, vol. 488, no. 2, pp. 119–133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  107. D. Tan, D. S. Goerlitz, R. G. Dumitrescu et al., “Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells,” Carcinogenesis, vol. 29, no. 6, pp. 1170–1177, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. J. A. Petros, A. K. Baumann, E. Ruiz-Pesini et al., “MtDNA mutations increase tumorigenicity in prostate cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 3, pp. 719–724, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. C. Costa, J. Incio, and R. Soares, “Angiogenesis and chronic inflammation: cause or consequence?” Angiogenesis, vol. 10, no. 3, pp. 149–166, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. C. Heeschen, M. Weis, A. Aicher, S. Dimmeler, and J. P. Cooke, “A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors,” Journal of Clinical Investigation, vol. 110, no. 4, pp. 527–536, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. J. P. Cooke and H. Bitterman, “Nicotine and angiogenesis: a new paradigm for tobacco-related diseases,” Annals of Medicine, vol. 36, no. 1, pp. 33–40, 2004. View at Publisher · View at Google Scholar · View at Scopus
  112. B. S. Conklin, W. Zhao, D. S. Zhong, and C. Chen, “Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells,” American Journal of Pathology, vol. 160, no. 2, pp. 413–418, 2002. View at Google Scholar · View at Scopus
  113. J. P. Cooke, “Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor,” Life Sciences, vol. 80, no. 24-25, pp. 2347–2351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. M. K. C. Ng, J. Wu, E. Chang et al., “A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 106–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. C. S. Carty, P. D. Soloway, S. Kayastha et al., “Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cells,” Journal of Vascular Surgery, vol. 24, no. 6, pp. 927–935, 1996. View at Publisher · View at Google Scholar · View at Scopus
  116. J. A. Ambrose and R. S. Barua, “The pathophysiology of cigarette smoking and cardiovascular disease: an update,” Journal of the American College of Cardiology, vol. 43, no. 10, pp. 1731–1737, 2004. View at Publisher · View at Google Scholar · View at Scopus
  117. H. R. Arias, V. E. Richards, D. Ng, M. E. Ghafoori, V. Le, and S. A. Mousa, “Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 7, pp. 1441–1451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. J. Jacobi, J. J. Jang, U. Sundram, H. Dayoub, L. F. Fajardo, and J. P. Cooke, “Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice,” American Journal of Pathology, vol. 161, no. 1, pp. 97–104, 2002. View at Google Scholar · View at Scopus
  119. Q. Zhang, X. Tang, Z. F. Zhang, R. Velikina, S. Shi, and A. D. Le, “Nicotine induces hypoxia-inducible factor-1α expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways,” Clinical Cancer Research, vol. 13, no. 16, pp. 4686–4694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. F. Costa and R. Soares, “Nicotine: a pro-angiogenic factor,” Life Sciences, vol. 84, no. 23-24, pp. 785–790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. R. D. Egleton, K. C. Brown, and P. Dasgupta, “Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases,” Pharmacology and Therapeutics, vol. 121, no. 2, pp. 205–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. Y. Kanda and Y. Watanabe, “Nicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cells,” Life Sciences, vol. 80, no. 15, pp. 1409–1414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. V. Y. Shin and C. H. Cho, “Nicotine and gastric cancer,” Alcohol, vol. 35, no. 3, pp. 259–264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  124. M. J. Jarzynka, P. Gou, I. Bar-Joseph, B. Hu, and S.-Y. Cheng, “Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis,” International Journal of Oncology, vol. 28, no. 2, pp. 337–344, 2006. View at Google Scholar
  125. P. K. Tithof, M. Elgayyar, H. M. Schuller, M. Barnhill, and R. Andrews, “4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine derivative, induces apoptosis of endothelial cells,” American Journal of Physiology, vol. 281, no. 5, pp. H1946–H1954, 2001. View at Google Scholar · View at Scopus
  126. J. P. Cooke and Y. T. Ghebremariam, “Endothelial nicotinic acetylcholine receptors and angiogenesis,” Trends in Cardiovascular Medicine, vol. 18, no. 7, pp. 247–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. S. Murin, K. E. Pinkerton, N. E. Hubbard, and K. Erickson, “The effect of cigarette smoke exposure on pulmonary metastatic disease in a murine model of metastatic breast cancer,” Chest, vol. 125, no. 4, pp. 1467–1471, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. G. E. Richardson, M. A. Tucker, D. J. Venzon et al., “Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers,” Annals of Internal Medicine, vol. 119, no. 5, pp. 383–390, 1993. View at Google Scholar
  129. P. Dasgupta, W. Rizwani, S. Pillai et al., “Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines,” International Journal of Cancer, vol. 124, no. 1, pp. 36–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  130. J. L. Su, C. Y. Yang, J. Y. Shih et al., “Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma,” Cancer Research, vol. 66, no. 5, pp. 2553–2561, 2006. View at Publisher · View at Google Scholar · View at Scopus
  131. Y.-H. Hung and W.-C. Hung, “4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) enhances invasiveness of lung cancer cells by up-regulating contactin-1 via the α7 nicotinic acetylcholine receptor/ERK signaling pathway,” Chemico-Biological Interactions, vol. 179, no. 2-3, pp. 154–159, 2009. View at Publisher · View at Google Scholar
  132. Y. Zong, S.-T. Zhang, and S.-T. Zhu, “Nicotine enhances migration and invasion of human esophageal squamous carcinoma cells which is inhibited by nimesulide,” World Journal of Gastroenterology, vol. 15, no. 20, pp. 2500–2505, 2009. View at Publisher · View at Google Scholar
  133. G. Chipitsyna, Q. Gong, R. Anandanadesan et al., “Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells,” International Journal of Cancer, vol. 125, no. 2, pp. 276–285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. M. Lazar, J. Sullivan, G. Chipitsyna et al., “Involvement of osteopontin in the matrix-degrading and proangiogenic changes mediated by nicotine in pancreatic cancer cells,” Journal of Gastrointestinal Surgery, vol. 14, no. 10, pp. 1566–1577, 2010. View at Publisher · View at Google Scholar
  135. M. E. Miller, A. C. Holloway, and W. G. Foster, “Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E (PGE) output,” Clinical and Experimental Metastasis, vol. 22, no. 2, pp. 149–156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  136. I. Yoshino, T. Kometani, F. Shoji et al., “Induction of epithelial-mesenchymal transition-related genes by benzo[a]pyrene in lung cancer cells,” Cancer, vol. 110, no. 2, pp. 369–374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. T. H. Ueng, Y. L. Chang, YI. Y. Tsai et al., “Potential roles of fibroblast growth factor-9 in the benzo(a)pyrene-induced invasion in vitro and the metastasis of human lung adenocarcinoma,” Archives of Toxicology, vol. 84, no. 8, pp. 651–660, 2010. View at Publisher · View at Google Scholar · View at Scopus
  138. B. J. Rollins, “Inflammatory chemokines in cancer growth and progression,” European Journal of Cancer, vol. 42, no. 6, pp. 760–767, 2006. View at Publisher · View at Google Scholar · View at Scopus
  139. S. Gelmini, M. Mangoni, M. Serio, P. Romagnani, and E. Lazzeri, “The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis,” Journal of Endocrinological Investigation, vol. 31, no. 9, pp. 809–819, 2008. View at Google Scholar · View at Scopus
  140. E. Martínez-García, M. Irigoyen, Ó. González-Moreno et al., “Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment,” Toxicological Sciences, vol. 116, no. 2, pp. 467–476, 2010. View at Publisher · View at Google Scholar
  141. J. B. Eells and T. Brown, “Repeated developmental exposure to chlorpyrifos and methyl parathion causes persistent alterations in nicotinic acetylcholine subunit mRNA expression with chlorpyrifos altering dopamine metabolite levels,” Neurotoxicology and Teratology, vol. 31, no. 2, pp. 98–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. R. Chen, C. Ho, and Y.-J. Wang, “Pterostilbene induces autophagy and apoptosis in sensitive and chemoresistant human bladder cancer cells,” Molecular Nutrition and Food Research, vol. 54, no. 12, pp. 1819–1832, 2010. View at Publisher · View at Google Scholar
  143. H. L. Lee, L. W. Chang, J. P. Wu et al., “Enhancements of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism and carcinogenic risk via NNK/arsenic interaction,” Toxicology and Applied Pharmacology, vol. 227, no. 1, pp. 108–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  144. C. L. Chen, L. I. Hsu, H. Y. Chiou et al., “Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan,” Journal of the American Medical Association, vol. 292, no. 24, pp. 2984–2990, 2004. View at Publisher · View at Google Scholar · View at Scopus
  145. Y.-J. Wang, H. Chang, Y.-C. Kuo et al., “Synergism between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumor incidence in mice,” Journal of Hazardous Materials, vol. 186, no. 1, pp. 869–875, 2010. View at Publisher · View at Google Scholar